These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37385694)

  • 1. Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care.
    Nigam K; Curseen KA; Beaussant Y
    Clin Geriatr Med; 2023 Aug; 39(3):423-436. PubMed ID: 37385694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.
    Niles H; Fogg C; Kelmendi B; Lazenby M
    BMC Palliat Care; 2021 Dec; 20(1):191. PubMed ID: 34930220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care.
    Ross S; Agrawal M; Griffiths RR; Grob C; Berger A; Henningfield JE
    Neuropharmacology; 2022 Sep; 216():109174. PubMed ID: 35772523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
    Schimmers N; Breeksema JJ; Smith-Apeldoorn SY; Veraart J; van den Brink W; Schoevers RA
    Psychopharmacology (Berl); 2022 Jan; 239(1):15-33. PubMed ID: 34812901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.
    Gold ND; Mallard AJ; Hermann JC; Zeifman RJ; Pagni BA; Bogenschutz MP; Ross S
    J Palliat Med; 2023 Oct; 26(10):1408-1418. PubMed ID: 37167080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychedelics for existential distress in terminally ill patients].
    Schimmel N; Breeksema JJ; Veraart JKE; van den Brink W; Schoevers RA
    Tijdschr Psychiatr; 2020; 62(8):659-668. PubMed ID: 32816294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential of Psychedelics for End of Life and Palliative Care.
    Yaden DB; Nayak SM; Gukasyan N; Anderson BT; Griffiths RR
    Curr Top Behav Neurosci; 2022; 56():169-184. PubMed ID: 34958455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.
    Rosa WE; Sager Z; Miller M; Bernstein I; Doerner Rinaldi A; Addicott K; Ljuslin M; Adrian C; Back AL; Beachy J; Bossis AP; Breitbart WS; Cosimano MP; Fischer SM; Guss J; Knighton E; Phelps J; Richards BD; Richards WA; Tulsky JA; Williams MT; Beaussant Y
    J Palliat Med; 2022 Aug; 25(8):1273-1281. PubMed ID: 35285721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness.
    Beaussant Y; Tulsky J; Guérin B; Schwarz-Plaschg C; Sanders JJ;
    J Palliat Med; 2021 Nov; 24(11):1657-1666. PubMed ID: 33848208
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.
    Jing X; Hoeh NR; Menkes DB
    Palliat Support Care; 2023 Aug; 21(4):697-704. PubMed ID: 37334486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychedelic-assisted psychotherapy in palliative medicine].
    Schaller A; Bourquin G; Amorim Araujo I; Ljuslin M
    Rev Med Suisse; 2023 Dec; 19(855):2395-2398. PubMed ID: 38117108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking Psychedelics Seriously.
    Byock I
    J Palliat Med; 2018 Apr; 21(4):417-421. PubMed ID: 29356590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Access to Psychedelics for Psychological Suffering at the End of Life - Prioritizing Our Priorities.
    Rosenbaum D; Hales S; Buchman DZ
    Healthc Policy; 2023 May; 18(4):143-148. PubMed ID: 37486819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.
    Johnston CB; Mangini M; Grob C; Anderson B
    Am J Geriatr Psychiatry; 2023 Jan; 31(1):44-53. PubMed ID: 36184377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey.
    Plourde L; Chang SL; Farzin H; Gagnon P; Hébert J; Foxman R; Deschamps P; Provost F; Masse-Grenier M; Stephan JF; Cheung K; Joly Y; Fallu JS; Dorval M;
    Palliat Med; 2024 Feb; 38(2):272-278. PubMed ID: 38253521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments.
    Greenway KT; Garel N; Jerome L; Feduccia AA
    Expert Rev Clin Pharmacol; 2020 Jun; 13(6):655-670. PubMed ID: 32478631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy.
    Dore J; Turnipseed B; Dwyer S; Turnipseed A; Andries J; Ascani G; Monnette C; Huidekoper A; Strauss N; Wolfson P
    J Psychoactive Drugs; 2019; 51(2):189-198. PubMed ID: 30917760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelics for psychological and existential distress in palliative and cancer care.
    Rosenbaum D; Boyle AB; Rosenblum AM; Ziai S; Chasen MR; Med MP
    Curr Oncol; 2019 Aug; 26(4):225-226. PubMed ID: 31548800
    [No Abstract]   [Full Text] [Related]  

  • 19. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
    Moreton SG; Szalla L; Menzies RE; Arena AF
    Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives.
    Beaussant Y; Sanders J; Sager Z; Tulsky JA; Braun IM; Blinderman CD; Bossis AP; Byock I
    J Palliat Med; 2020 Oct; 23(10):1323-1334. PubMed ID: 32233936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.